Dr Dina Radenkovic is Co-founder and CEO of Gameto, a biotechnology company using cell engineering to develop novel therapeutics for the diseases of the female reproductive system, focusing on infertility and menopause.
Beyond Gameto, Dina is Partner at SALT Bio Fund. She has had research posts at King’s College London and the Buck Institute for Research on Aging. Dina was also
Co-founder & Chief Science Officer of Hooke, longevity research clinics.
She qualified with a dual degree in medicine and physiology from UCL Medical School, London, UK, and did her residency at St Thomas’ Hospital in London.